Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Atovaquone × 90 days × Clear all

Phase

Phase EARLY_PHASE1 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Locally Advanced Non-Small Cell Lung Cancer 1

Interventions

Specimen Handling 117 pembrolizumab 115 Cyclophosphamide 99 Magnetic Resonance Spectroscopy 94 Biopsy 88 fludarabine 75 Nivolumab 55 venetoclax 49 Carboplatin 36 Radiotherapy 35 Cetuximab 34 fludarabine phosphate 33 Paclitaxel 33 Gemcitabine 32 Cisplatin 32 Bevacizumab 32 Fluorouracil 30 atezolizumab 28 Azacitidine 28 Ipilimumab 25 Dexamethasone 25 Cytarabine 25 durvalumab 24 Temozolomide 24 Lenalidomide 24 Injections 24 Radiosurgery 23 Oxaliplatin 23 Leucovorin 22 Irinotecan 22

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04648033 2026-01-29

ARCADIAN

University of Oxford

Phase 1 Completed

21 enrolled 21 charts

Locally Advanced Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡